fig3

Figure 3. Clinical outcomes in DCM patients with and without rare deleterious variants in FBN1. (A) Kaplan-Meier curve illustrates survival free of primary endpoints, which include cardiac mortality or heart transplantation. (B) The curve represents survival free of secondary endpoints, comprising all-cause mortality or heart failure recurrence. Probability values were calculated using the log-rank test. FBN1⁺: DCM cases carrying rare deleterious variants in FBN1; FBN1^-: DCM cases not carrying rare deleterious variants in FBN1.